Surgical Quality Improvement

Dermatology & Plastic Surgery Institute Outcomes

Dermatology & Plastic Surgery Institute Surgery ACS NSQIP Outcomes

January 1, 2022 – December 31, 2022

The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) objectively measures and reports risk-adjusted surgical outcomes based on a defined sampling and abstraction methodology. These outcomes data reflect Cleveland Clinic’s Dermatology & Plastic Surgery Institute surgery ACS NSQIP performance benchmarked against 468 participating sites.

Dermatology & Plastic Surgery (468 Sites)NObservedExpected
30 Day Morbidity3513.70%5.64%
Ventilator > 48 Hours3510.00%0.01%
Deep Vein Thrombosis (DVT) / Pulmonary Embolus3510.85%0.45%
Renal Failure3510.00%0.11%
Urinary Tract Infection (UTI)3510.28%0.23%
Surgical Site Infection (SSI)3493.15%4.47%
C.diff Colitis3510.00%0.06%
Unplanned Reoperation3515.70%5.29%
Unplanned Readmissionᵃ3515.41%2.79%

American College of Surgeons National Surgical Quality Improvement Program, 2023.
ACS NSQIP® Semiannual Report July 3, 2023, Chicago: American College of Surgeons.

ᵃIdentified as a statistical outlier (higher than expected) by the ACS NSQIP hierarchical model.